Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Direct oral anticoagulants: Competition brought no cost relief

    July 27, 2021

    Medicare Part D spending since 2011 has far outpaced growth in the use of oral anticoagulants.

  • Article

    Rising meth-related heart failure admissions a ‘crisis,’ costly for society

    July 23, 2021

    ‘They’re not going to die from it overnight, but it will damage the heart slowly,’ a researcher said. Meth-related HF admissions exploded in the western United States over a recent decade.

  • 1
    News

    Statins again linked to lower COVID-19 mortality

    July 21, 2021

    Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t in a large observational study.

  • 1
    News

    Pharmacologic and electrical cardioversion of acute Afib reduces hospital admissions

    July 20, 2021

    Is pharmacologic cardioversion and/or electrical cardioversion an appropriate initial management strategy for acute atrial fibrillation?

  • 1
    News

    DOACs linked to lower mortality than vitamin K antagonist: 3-year TAVR registry

    July 16, 2021

    Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.

  • News

    Long-term outcome data suggest optimism for MIS-C patients

    July 16, 2021

    Most inflammatory and cardiac manifestations of multisystem inflammatory syndrome in children resolved by 9 months.

  • News

    New details of myocarditis linked to COVID vaccines

    July 2, 2021

    Further details from multiple cases of myocarditis linked to the Pfizer and Moderna mRNA COVID vaccines have been described in recent papers in the medical literature.

  • 1
    News

    Abnormal exercise EKG in the setting of normal stress echo linked with increased CV risk

    June 28, 2021

    What is the significance of an abnormal exercise EKG with a normal stress echo?

  • 1
    News

    FDA to add myocarditis warning to mRNA COVID-19 vaccines

    June 24, 2021

    But a CDC advisory panel, where the FDA made the announcement, still strongly backs the vaccines’ benefits, which outweigh the rare risk for heart inflammation.

  • 1
    News

    Sotagliflozin use in T2D patients linked with posthospitalization benefits in analysis

    June 23, 2021

    The paper’s outcome measure may be a meaningful, patient-centered way of capturing disease burden, according to the authors.

Previous1 … 10 11 12 13 14 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences